This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Markus Muttenthaler, PhD
Associate Professor, Neuropeptide Research at The University of Queensland and University of Vienna
Speaker

Profile

Associate Professor Markus Muttenthaler is an ARC Future Fellow heading the Neuropeptide Research Lab at the Institute for Molecular Bioscience at the University of Queensland, Australia, with a second affiliation at the Institute of Biological Chemistry at the University of Vienna, Austria. He is a medicinal chemist working at the interface of chemistry and biology with a strong passion for translational research. His research focuses on bioactive peptides and exploring nature's biodiversity to develop molecular tools, diagnostics and therapeutics. His background in drug discovery and development, as well as his interdisciplinary training in the fields of chemistry, molecular biology, and pharmacology assist him in the characterisation of these highly potent and selective compounds and allow him to study their interactions with human physiology for medical innovations in pain, cancer, autism, and gastrointestinal disorders.

Agenda Sessions

  • Oral Peptide Therapeutics for Gut Disorders

    2:15pm